Cliff Holloway
Direttore/Membro del Consiglio presso Newstar Ventures Ltd.
Profilo
Cliff Holloway is currently the Director at Newstar Ventures Ltd.
Prior to his current position, he served as the Chief Executive Officer & Director at Scancell Holdings Plc from 2018 to 2021.
He also held the position of Managing Director & Chief Executive Officer at Sienna Cancer Diagnostics Ltd., Chief Executive Officer & Director at Scancell Ltd., Managing Director at Biosceptre (Aust) Pty Ltd., and Managing Director at Immune System Therapeutics Ltd.
From 2006 to 2011, he worked as the VP-Business Development & Products at Arana Therapeutics Ltd.
Additionally, he served as the Chief Operating & Business Officer at Benitec Biopharma Ltd.
from 2016 to 2018.
Dr. Holloway obtained his undergraduate and doctorate degrees from The University of Nottingham.
Posizioni attive di Cliff Holloway
Società | Posizione | Inizio |
---|---|---|
Newstar Ventures Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Cliff Holloway
Società | Posizione | Fine |
---|---|---|
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Amministratore Delegato | 28/07/2021 |
SCANCELL HOLDINGS PLC | Amministratore Delegato | 28/07/2021 |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Direttore operativo | 01/01/2018 |
Arana Therapeutics Ltd.
Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | 07/07/2011 |
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Amministratore Delegato | - |
Formazione di Cliff Holloway
The University of Nottingham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCANCELL HOLDINGS PLC | Health Technology |
Aziende private | 7 |
---|---|
Arana Therapeutics Ltd.
Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Health Technology |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Health Technology |
Sienna Cancer Diagnostics Ltd.
Sienna Cancer Diagnostics Ltd. BiotechnologyHealth Technology Sienna Cancer Diagnostics Ltd. operates as a medical technology company. It delivers sensitive, novel, robust and test for early detection of cancer, assessment of cancer treatments and assistance in drug development. The company was founded in 2002 and is headquartered in Scoresby, Australia. | Health Technology |
Immune System Therapeutics Ltd.
Immune System Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Immune System Therapeutics Ltd. engages in the development and commercialization of monoclonal antibodies to treat human blood cancers. The company was founded by Alan Liddle and Rosanne Dunn and is headquartered in Ultimo, Australia. | Health Technology |
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
Newstar Ventures Ltd. | |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Cliff Holloway